相关实验视频

Updated: May 27, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

综合分析确定Hsa_circ_0058191是多发性骨髓瘤中潜在的耐药性目标

Huiye Yang¹, Jie Zhu¹, Xiaotao Wang¹

¹Department of Hematology, The Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.

OncoTargets and therapy

|February 18, 2025

概括

这项研究确定hsa_circ_0058191作为一个关键的循环RNA,在多发性骨髓瘤 (MM) 中驱动博特佐米布耐药性. 了解这种机制为克服MM患者的耐药性提供了新的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

多发性骨髓瘤 (MM) 是一种常见的血液性恶性瘤,以其对第一线治疗方法博特佐米布的耐药性而闻名.
循环RNAs (circRNAs) 与癌症药物耐药性有关,但它们在MM中的特定作用在很大程度上仍未被描述.

研究的目的:

识别和研究涉及多发性髓瘤中博特佐米布耐药性的circRNAs.
阐明MM中循环RNA介导的耐药性背后的分子机制.

主要方法:

使用微阵列对抗博特佐米布的MM患者的circRNAs的查.
对公共MM数据集 (GEO数据库) 的生物信息分析,以确定候选circRNAs.
通过qRT-PCR验证circRNA表达,并使用CircInteractome和Metascape预测miRNA/RBP相互作用.

主要成果:

hsa_circ_0058191在抗博特佐米布的MM样本中显著过度表达.
hsa_circ_0058191与miR-660和AGO2相互作用,调节RNA修饰和mRNA通路.
这些相互作用为MM的药物耐药性的分子基础提供了洞察力.

结论:

hsa_circ_0058191在多发性髓瘤中对博尔特佐米布耐药性的发展中起着至关重要的作用.
这一发现为开发新的治疗策略提供了理论基础,以打击MM的耐药性.

关键词:

生物信息分析分析生物信息分析环RNA 环RNA 是一个环RNA.药物耐药性耐药性药物耐药性多发性骨髓瘤是多发性骨髓瘤的一种疾病.治疗的目标是治疗目标.

更多相关视频

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...